TBH Global Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

TBH Global Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Sell	554 -15	-3%	-$6.65K	0.05%	248
2026 Q1	$254K	Sell	569 -23	-4%	-$10.7K	0.05%	243
2025 Q4	$269K	Buy	+592	New	+$255K	0.04%	226
2025 Q3	–	Sell	-569	Closed	-$253K	–	258
2025 Q2	$253K	Sell	569 -44	-7%	-$20.3K	0.05%	171
2025 Q1	$297K	Buy	+613	New	+$286K	0.06%	157

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TBH Global Asset Management's VRTX Position: Q2 2026 in Review

TBH Global Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.6% in Q2 2026, selling an estimated $6.65K and leaving 554 shares worth $275K. The position accounts for 0.05% of the portfolio, ranked #248.

TBH Global Asset Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $297K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

TBH Global Asset Management held 554 shares of Vertex Pharmaceuticals worth $275K as of Q2 2026.
TBH Global Asset Management sold 15 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.65K.
Vertex Pharmaceuticals made up 0.05% of TBH Global Asset Management's portfolio in Q2 2026, its #248 holding.
TBH Global Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
TBH Global Asset Management's Vertex Pharmaceuticals position peaked at $297K in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TBH Global Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.